Global and At-Home Drug of Abuse (DOA) Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis 4
  • 1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate 4: 2020 VS 2026
  • 1.2.2 Test Cups
  • 1.2.3 Test Dip Cards
  • 1.2.4 Test Strips
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Share 4: 2020 VS 2026
  • 1.3.2 Urine
  • 1.3.3 Saliva
  • 1.3.4 Hair
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2015-2026)
• 2.2 Global At-Home Drug of Abuse (DOA) Testing Growth Trends by Regions
  • 2.2.1 At-Home Drug of Abuse (DOA) Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Market Size
  • 3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2015-2020)
  • 3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2015-2020)
• 3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
• 3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
  • 3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2019
• 3.5 Key Players At-Home Drug of Abuse (DOA) Testing Area Served
• 3.6 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
• 3.7 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 At-Home Drug of Abuse (DOA) Testing Breakdown Data 4 (2015-2026)

• 4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size 4 (2015-2020)
• 4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size 4 (2021-2026)

5 At-Home Drug of Abuse (DOA) Testing Breakdown Data 4 (2015-2026)

• 5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size 4 (2015-2020)
• 5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size 4 (2021-2026)

6 North America

• 6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2015-2026)
• 6.2 North America At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
• 6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
• 6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2015-2026)
• 7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
• 7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
• 7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China At-Home Drug of Abuse (DOA) Testing Market Size (2015-2026)
• 8.2 China At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
• 8.3 China At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
• 8.4 China At-Home Drug of Abuse (DOA) Testing Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan At-Home Drug of Abuse (DOA) Testing Market Size (2015-2026)
• 9.2 Japan At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
• 9.3 Japan At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
• 9.4 Japan At-Home Drug of Abuse (DOA) Testing Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size (2015-2026)
• 10.2 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
• 10.3 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)
• 10.4 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 UCP Biosciences
  • 11.1.1 UCP Biosciences Company Details
  • 11.1.2 UCP Biosciences Business Overview
  • 11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
  • 11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020))
  • 11.1.5 UCP Biosciences Recent Development
• 11.2 Orient New Life Medical
  • 11.2.1 Orient New Life Medical Company Details
  • 11.2.2 Orient New Life Medical Business Overview
  • 11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
  • 11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
  • 11.2.5 Orient New Life Medical Recent Development
• 11.3 Express Diagnostics Int’l
  • 11.3.1 Express Diagnostics Int’l Company Details
  • 11.3.2 Express Diagnostics Int’l Business Overview
  • 11.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Introduction
  • 11.3.4 Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
  • 11.3.5 Express Diagnostics Int’l Recent Development
• 11.4 Assure Tech (Hangzhou)
  • 11.4.1 Assure Tech (Hangzhou) Company Details
  • 11.4.2 Assure Tech (Hangzhou) Business Overview
  • 11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
  • 11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
  • 11.4.5 Assure Tech (Hangzhou) Recent Development
• 11.5 Psychemedics Corporation
  • 11.5.1 Psychemedics Corporation Company Details
  • 11.5.2 Psychemedics Corporation Business Overview
  • 11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
  • 11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
  • 11.5.5 Psychemedics Corporation Recent Development
• 11.6 Confirm BioSciences
  • 11.6.1 Confirm BioSciences Company Details
  • 11.6.2 Confirm BioSciences Business Overview
  • 11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
  • 11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
  • 11.6.5 Confirm BioSciences Recent Development
• 11.7 Phamatech
  • 11.7.1 Phamatech Company Details
  • 11.7.2 Phamatech Business Overview
  • 11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
  • 11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
  • 11.7.5 Phamatech Recent Development
• 11.8 Home Health (U.K.) Ltd.
  • 11.8.1 Home Health (U.K.) Ltd. Company Details
  • 11.8.2 Home Health (U.K.) Ltd. Business Overview
  • 11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
  • 11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
  • 11.8.5 Home Health (U.K.) Ltd. Recent Development
• 11.9 Quest Products
  • 11.9.1 Quest Products Company Details
  • 11.9.2 Quest Products Business Overview
  • 11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
  • 11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
  • 11.9.5 Quest Products Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer